Mehrotra Rajnish, Williamson Don E, Betts C Ross, Greco Barbara A, Yu Eric, El-Badry Aly, Fisher Brian, Mehoudar Paul D, Briggs Benjamin, Chertow Glenn M
Division of Nephrology, Department of Medicine, University of Washington School of Medicine, Seattle, Washington, USA.
CloudCath, Inc., San Francisco, California, USA.
Kidney Int Rep. 2024 Jan 28;9(4):929-940. doi: 10.1016/j.ekir.2024.01.033. eCollection 2024 Apr.
Peritonitis is the leading complication of peritoneal dialysis (PD). Patients are instructed to seek care promptly for signs (cloudy effluent) or symptoms (abdominal pain), and earlier treatment improves outcomes. The CloudCath Peritoneal Dialysis Drain Set Monitoring (CloudCath) system monitors turbidity in dialysis effluent and sends notifications of changes signaling possible peritonitis.
We conducted this single-arm, open-label, multicenter study of CloudCath system use during PD. We deactivated system notifications to participants and investigators, who followed standard-of-care for peritonitis signs and symptoms. Effectiveness endpoints measured time between CloudCath system notifications and peritonitis events using International Society of Peritoneal Dialysis (ISPD) criteria.
Two hundred forty-three participants used the CloudCath system for 178.8 patient-years. Of 71 potential peritonitis events, 51 events (0.29 per patient-year) met ISPD white blood cell (WBC) count criteria. The system triggered notifications for 41 of 51 events (80.4%), with a median lead time of 2.6 days (10%-90% range, -1.0 to 15.7; < 0.0001). Excluding 6 peritonitis events that occurred when the system was not in use, the system triggered notifications for 41 of 45 events (91.1%), with a median lead time of 3.0 days (10%-90% range, -0.5 to 18.8; < 0.0001). Of the 0.78 notifications per patient-year, the majority were peritonitis events or nonperitonitis events such as exit site and tunnel infections or catheter/cycler issues.
The CloudCath system detected peritonitis events during PD several days earlier than the current standard-of-care and has the capacity to send notifications that could expedite peritonitis diagnosis and treatment.
腹膜炎是腹膜透析(PD)的主要并发症。患者被要求一旦出现体征(透出液浑浊)或症状(腹痛)就立即就医,早期治疗可改善预后。CloudCath腹膜透析引流套装监测系统(CloudCath)可监测透析透出液的浑浊度,并发送变化通知以提示可能发生腹膜炎。
我们开展了这项关于PD期间使用CloudCath系统的单臂、开放标签、多中心研究。我们停用了系统对参与者和研究者的通知,他们遵循腹膜炎体征和症状的标准治疗方案。有效性终点指标采用国际腹膜透析学会(ISPD)标准,测量CloudCath系统发出通知与腹膜炎事件之间的时间间隔。
243名参与者使用CloudCath系统达178.8患者年。在71起潜在腹膜炎事件中,51起事件(每患者年0.29起)符合ISPD白细胞(WBC)计数标准。该系统触发了51起事件中41起(80.4%)的通知,中位提前时间为2.6天(10% - 90%范围,-1.0至15.7;<0.0001)。排除系统未使用时发生的6起腹膜炎事件后,该系统触发了45起事件中41起(91.1%)的通知,中位提前时间为3.0天(10% - 90%范围,-0.5至18.8;<0.0001)。在每患者年0.78次通知中,大多数是腹膜炎事件或非腹膜炎事件,如出口处和隧道感染或导管/循环器问题。
CloudCath系统在PD期间比当前标准治疗方案提前数天检测到腹膜炎事件,并有能力发送通知以加快腹膜炎的诊断和治疗。